1. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1?17, 1988
2. Walker MD, Alexander E, Jr., Hunt WE, MacCarty CS, Mahaley MS, Mealy J, Norrell HA, Owens G, RansohoffJ, Wilson CB, Gehan EA, Strike TE: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastie gliomas. A cooperative clinical trial. J Neurosurg 49: 333?343, 1978
3. Walker MD, Green SB, Byar BP, Alexander EJ, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Jr., Mealey J, Jr., Owens G, Ransohoff J, II, Robertson JT, Shapiro WR, Smith KR, Jr., Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for malignant glioma after surgery. N Engl J Med 303: 1323?1329,1980
4. Shapiro WR, Green SB: Re-evaluating the efficacy of intra-arterial BCNU. J Neurosurg 66: 313?315, 1987
5. Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Jr., Batzdorf U, Brooks WH, Hunt WE, Mealey J, Jr., Odom GL, Paoletti P, Ransohoff J, II, Robertson JT, Selke RG, Shapiro WR, Smith KR, Jr., Wilson CB, Strike TA: Comparisons of carmustine, procarbazine, and high-dose methylpredmisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 121?132, 1983